A Facile NMR Method for Pre-MRI Evaluation of Trigger-Responsive T 1 Contrast Enhancement.
Cheng-Bang JianYing-Yann WuMing-Huang LinHua-De GaoChong-Yan ChenShwee Khuan LeongDer-Lii M TzouDennis W HwangHsien-Ming LeePublished in: Small methods (2024)
There is a growing interest in developing paramagnetic nanoparticles as responsive magnetic resonance imaging (MRI) contrast agents, which feature switchable T 1 image contrast of water protons upon biochemical cues for better discerning diseases. However, performing an MRI is pragmatically limited by its cost and availability. Hence, a facile, routine method for measuring the T 1 contrast is highly desired in early-stage development. This work presents a single-point inversion recovery (IR) nuclear magnetic resonance (NMR) method that can rapidly evaluate T 1 contrast change by employing a single, optimized IR pulse sequence that minimizes water signal for "off-state" nanoparticles and allows for sensitively measuring the signal change with "switch-on" T 1 contrast. Using peptide-induced liposomal gadopentetic acid (Gd 3+ -DTPA) release and redox-sensitive manganese oxide (MnO 2 ) nanoparticles as a demonstration of generality, this method successfully evaluates the T 1 shortening of water protons caused by liposomal Gd 3+ -DTPA release and Mn 2+ formation from MnO 2 reduction. Furthermore, the NMR measurement is highly correlated to T 1 -weighted MRI scans, suggesting its feasibility to predict the MRI results at the same field strength. This NMR method can be a low-cost, time-saving alternative for pre-MRI evaluation for a diversity of responsive T 1 contrast systems.
Keyphrases
- contrast enhanced
- magnetic resonance
- magnetic resonance imaging
- diffusion weighted imaging
- computed tomography
- early stage
- high resolution
- low cost
- cancer therapy
- deep learning
- machine learning
- blood pressure
- clinical practice
- lymph node
- radiation therapy
- squamous cell carcinoma
- oxidative stress
- mass spectrometry
- diabetic rats
- room temperature
- reduced graphene oxide
- high glucose
- neoadjuvant chemotherapy